The next is a abstract of some latest research on COVID-19. They embrace analysis that warrants additional examine to corroborate the findings and that has but to be licensed by peer evaluate.
COVID-19 worsens bronchial asthma in kids
Bronchial asthma in kids could worsen after an an infection with the coronavirus, medical doctors warn.
They studied practically 62,000 U.S. kids with bronchial asthma who had PCR assessments for the virus within the first 12 months of the pandemic, together with greater than 7,700 who examined constructive. Contaminated kids had considerably extra bronchial asthma visits, hospitalizations, emergency inhaler use, and steroid remedies in the course of the six months after their sickness in comparison with kids who examined destructive and to their very own prior historical past, researchers reported within the Journal of Allergy and Scientific Immunology: In Apply. Youngsters who examined destructive for the virus “had improved bronchial asthma management for the subsequent six months, which means fewer emergency division visits and hospitalizations for bronchial asthma, and fewer bronchial asthma therapy,” stated Dr. Christine Chou of Youngsters’s Well being of Orange County, in California.
Outcomes of earlier research displaying enchancment in bronchial asthma management within the early a part of the pandemic have been possible as a result of public well being measures like staying residence and masking, which curbed publicity to bronchial asthma triggers, she stated. Regardless of the general impression that kids with bronchial asthma did nicely in the course of the first 12 months of the pandemic, Chou added, the brand new examine reveals “longer lasting hurt of COVID on kids’s bronchial asthma management.”
Booster after an infection provides little additional profit vs Omicron
Amongst individuals who have been beforehand contaminated with the coronavirus, a 3rd dose of an mRNA vaccine from Pfizer/BioNTech or Moderna could not enhance their safety towards the Omicron variant of the virus, based on new information.
Researchers studied practically 130,000 individuals examined for COVID in Connecticut from November 2021 by way of January 2022, together with 10,676 with Omicron infections. Roughly 6% to eight% had been contaminated with earlier variations of the coronavirus, based on a report posted on medRxiv forward of peer evaluate. Two doses of an mRNA vaccine did assist defend towards Omicron amongst individuals with prior infections, however “we didn’t detect a further good thing about receiving a 3rd booster dose amongst this inhabitants,” stated Margaret Lind of Yale College.
A separate examine from Canada, additionally posted on medRxiv forward of peer evaluate, equally discovered that greater than two vaccine doses “could also be of marginal incremental worth” for shielding previously-infected people towards Omicron. The message, Lind stated, “must be that (1) individuals ought to get two doses of mRNA vaccine no matter if they’ve had a previous an infection or not, that (2) individuals with out prior infections ought to get a booster dose and that (3) individuals with prior infections ought to contemplate a booster dose, particularly if they’re in a excessive threat group for all times threatening problems, however acknowledge that it might not present vital further safety towards an infection above two doses.”